Literature DB >> 9728244

Management of recurrent craniopharyngioma.

M Caldarelli1, C di Rocco, F Papacci, C Colosimo.   

Abstract

Although histologically benign, craniopharyngioma can regrow either from macroscopic remnants of the tumour left behind at operation, or even after an apparently gross total removal. Recurrence rates vary significantly in the literature, depending on the efficacy of surgical treatment and also on the growth potential of the tumour itself. The main factor influencing tumour regrowth is obviously the extent of surgical resection, as total removal carries a much lesser risk of recurrence compared to subtotal or partial resections (although in such cases radiation therapy can lower this risk significantly). Other factors involved are the duration of follow-up and patient's age at operation, as children tend to relapse more frequently than adults. Even in the "microsurgery" era, characterized by high percentages of total resections, recurrences remain high and continue to represent a major problem of craniopharyngioma treatment. Twenty-seven children and adolescents were operated on for craniopharyngioma at the Department of Neurosurgery, Section of Pediatric Neurosurgery, Catholic University Medical School, Rome between June 1985 and June 1997. Total tumour resection was achieved in 18 cases, subtotal in 7 and partial in 2 instances. One patient died post-operatively. Post-operative neuroradiological investigations confirmed the operative findings, although 3 children with an apparently gross total removal showed a residual non-enhancing calcium fleck adherent to the hypothalamus (which remained stable at the following examinations). Three of the 9 patients with less than total removal underwent post-operative radiation therapy. Out of the 26 surviving patients 6 presented a recurrence of their craniopharyngioma, 2 after an apparently gross total removal and 4 after a subtotal or partial resection (one of them had received radiation therapy). The diagnosis was merely neuroradiological in 5 cases, as only one child presented a clinical picture suggestive of tumour regrowth. Surgery was the first therapeutic option in all the cases. Total tumour resection was accomplished in 3 cases, subtotal in 2 and partial in the last one. One child died post-operatively. Four of the 5 survivors received radiation therapy. All the patients are presently alive and stable (mean follow-up: 5.6 yrs). The authors conclude that surgery should be the first therapeutic option in case of recurrent craniopharyngioma and that radiation therapy should also be considered but only as adjuvant therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9728244     DOI: 10.1007/s007010050123

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  11 in total

1.  The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas.

Authors:  Jessica K Schefter; George Allen; Anthony J Cmelak; Mahlon Johnson; Steven Toms; Dennis Duggan; Lewis S Blevins
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

Review 2.  Intracavitary therapeutic options in the management of cystic craniopharyngioma.

Authors:  Adrián Cáceres
Journal:  Childs Nerv Syst       Date:  2005-07-19       Impact factor: 1.475

3.  "Conservative" surgical approach and early postoperative radiotherapy in a patient with a huge cystic craniopharyngioma.

Authors:  Mario Francesco Fraioli; Riccardo Santoni; Chiara Fraioli; Filiberto Contratti
Journal:  Childs Nerv Syst       Date:  2005-11-30       Impact factor: 1.475

4.  Influence of previous treatments on repeat surgery for recurrent craniopharyngiomas in children.

Authors:  Yun Bao; Binghui Qiu; Songtao Qi; Jun Pan; Yuntao Lu; Junxiang Peng
Journal:  Childs Nerv Syst       Date:  2016-01-12       Impact factor: 1.475

5.  Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.

Authors:  M Caldarelli; L Massimi; G Tamburrini; M Cappa; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2005-07-02       Impact factor: 1.475

6.  Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children.

Authors:  Hiroshi Takahashi; Fumio Yamaguchi; Akira Teramoto
Journal:  Childs Nerv Syst       Date:  2005-06-01       Impact factor: 1.475

Review 7.  Craniopharyngioma: the pendulum of surgical management.

Authors:  Christian Sainte-Rose; Stéphanie Puget; Alison Wray; Michel Zerah; Jacques Grill; Raja Brauner; Nathalie Boddaert; Alain Pierre-Kahn
Journal:  Childs Nerv Syst       Date:  2005-08-03       Impact factor: 1.475

8.  Craniopharyngioma and hypothalamic obesity in children.

Authors:  Matthieu Vinchon; Jacques Weill; Isabelle Delestret; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2008-12-05       Impact factor: 1.475

9.  Craniopharyngiomas in children: recurrence, reoperation and outcome.

Authors:  Matthieu Vinchon; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2007-09-05       Impact factor: 1.475

10.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.